Awakn Life Sciences Corp.
OTC: AWKNF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Anthony Tennyson
- Employees
- 6
- Headquarters
- Toronto, Canada
- IPO year
- 2021
- Market cap
- $2.7M
- Website
- https://awaknlifesciences.com
Loading AWKNF…
Loading profile data…Frequently asked questions about AWKNF
What does Awakn Life Sciences Corp. (AWKNF) do?
Awakn Life Sciences Corp., a biotechnology firm, focuses on pioneering, advancing, implementing, and distributing psychedelic therapies to combat addiction and various other mental health conditions. Operating across the United Kingdom and Europe, the company maintains its corporate headquarters in Toronto, Canada.
Where does AWKNF trade?
Awakn Life Sciences Corp. (AWKNF) trades on the Other OTC.
What sector is AWKNF in?
Awakn Life Sciences Corp. (AWKNF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Awakn Life Sciences Corp.?
Anthony Tennyson is the chief executive officer of Awakn Life Sciences Corp. (AWKNF).
Where is Awakn Life Sciences Corp. headquartered?
Awakn Life Sciences Corp. is headquartered in Canada.
Does AWKNF pay a dividend?
Awakn Life Sciences Corp. (AWKNF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AWKNF go public?
Awakn Life Sciences Corp. (AWKNF) completed its initial public offering in 2021.